https://fromoraltohealth.com/wp-content/uploads/2023/01/bn-18.jpg8001980agent36/wp-content/uploads/2025/09/logo.svgagent362025-09-22 13:21:152025-10-29 15:16:29Phamacetical authorization contract signed with US FDA dry-eye indication approved for phase III